1. HDAC inhibitors trigger apoptosis in HPV-positive cells by inducing the E2F–p73 pathway
- Author
-
Christian Kuntzen, Andreas Krueger, Ubaldo Soto, Michael Stöhr, Patrick Finzer, Frank Rösl, Peter H. Krammer, and Dirk Brenner
- Subjects
Cancer Research ,Cyclin E ,Proteolysis ,Apoptosis ,Cell Cycle Proteins ,Receptors, Fc ,Biology ,medicine.disease_cause ,Membrane Potentials ,Genetics ,medicine ,Humans ,Protein Isoforms ,Genes, Tumor Suppressor ,Tumor Protein p73 ,Enzyme Inhibitors ,RNA, Small Interfering ,E2F ,Papillomaviridae ,Molecular Biology ,DNA Primers ,Base Sequence ,medicine.diagnostic_test ,Tumor Suppressor Proteins ,Nuclear Proteins ,Intracellular Membranes ,HDAC1 ,E2F Transcription Factors ,Mitochondria ,DNA-Binding Proteins ,Histone Deacetylase Inhibitors ,Cancer research ,Histone deacetylase ,biological phenomena, cell phenomena, and immunity ,Carcinogenesis ,E2F1 Transcription Factor ,HeLa Cells ,Transcription Factors - Abstract
Histone deacetylase (HDAC) inhibitors induce an intrinsic type of apoptosis in human papillomavirus (HPV)-positive cells by disrupting the mitochondrial transmembrane potential (deltapsim). Loss of deltapsim was only detected in E7, but not in E6 oncogene-expressing cells. HDAC inhibition led to a time-dependent degradation of the pocket proteins pRb, p107 and p130, releasing 'free' E2F-1 following initial G1 arrest. Inhibition of proteasomal proteolysis, but not of caspase activity rescued pRb from degradation and functionally restored its inhibitory effect on the cyclin E gene, known to be suppressed by pRb-E2F-1 in conjunction with HDAC1. Using siRNA targeted against p53, E2F-1 still triggered apoptosis by inducing the E2F-responsive proapoptotic alpha- and beta-isoforms of p73. These data may determine future therapeutic strategies in which HDAC inhibitors can effectively eliminate HPV-positive cells by an apoptotic route that does not rely on the reactivation of the 'classical' p53 pathway through a preceding shut-off of viral gene expression.
- Published
- 2004